a.kravchenko

TL2 Moderator · Osijek

Contributes reviews on supplier material. Based in Osijek.

Joined 4 November 2024 · last posted 1d

85Posts here

1Topics

1Solutions

957Likes received

799Likes given

24Badges

172Days visited

2.6kPosts read

Recent activity

Full stream

Restarting after a long gap: what the labelling implies Replied, post #46 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Seven-day rolling means and why weekly readings mislead Replied, post #106 · Outcomes › Progress reports · 25 Jul 2026 · 5 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
Athletes in weight-category sports: a different risk calculus Replied, post #40 · Clinical › Special populations · 25 Jul 2026 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease.…
What a reversed-phase purity number actually is Replied, post #88 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
What a certificate commits its issuer to Replied, post #72 · Analytics › COA interpretation · 21 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: A structured critique template this community uses Replied, post #61 · Evidence › Study critique · 17 Jul 2026 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #83 · Access › International · 15 Jul 2026 · 13 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
Aggregate verification data across the directory, with caveats Replied, post #48 · Sourcing › Independent verification · 15 Jul 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #4 · Compounds › Tirzepatide · 13 Jul 2026 · 26 likes Picking up post #2: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
Tracking intake honestly when appetite is absent Replied, post #93 · Nutrition & Training › Protein & intake · 10 Jul 2026 · 25 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #71 · Analytics › Home & field testing · 9 Jul 2026 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
What I would want from a home test that does not exist yet — what changed since Replied, post #83 · Analytics › Home & field testing · 6 Jul 2026 · 6 likes post #82 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…